AOD-9604 5mg

AOD-9604 5mg
£50.00

(NOT FOR HUMAN CONSUMPTION RESEARCH USE ONLY) 

AOD-9604

is a synthetic 16-amino acid peptide fragment of human growth hormone (HGH) that was originally developed for obesity treatment. It is not currently approved for human medical use and is banned in professional sports.

Function and Mechanism

AOD-9604 was engineered to target the fat-burning (lipolytic) properties of HGH while avoiding the growth-promoting effects (like bone growth or changes in insulin sensitivity) associated with the full hormone molecule.

  • Lipolysis: It primarily stimulates the breakdown of fat from adipose tissue (fat cells) and encourages the body to burn this fat for energy.
  • No Insulin Impact: A key safety feature observed in trials was that it did not negatively affect carbohydrate metabolism or glucose levels, which distinguishes it from full Hspectrum HGH.
  • Safety Profile: In clinical trials, its side effect profile was similar to a placebo, with no evidence of antibodies forming against it.

 

Clinical Trials and Efficacy

While AOD-9604 was found to be safe in human trials, it ultimately failed to show significant efficacy for weight loss.

     

    Regulatory Status

    • FDA Status: AOD-9604 is not an FDA-approved prescription medication. In December 2024, the FDA decided it should not be included on the list of bulk drug substances for pharmaceutical compounding due to concerns over long-term safety data and potential impurities. [1]
    • WADA Status: It is a prohibited substance under the World Anti-Doping Agency (WADA) Prohibited List.
    • Availability: It is primarily sold online as a "research chemical" intended for laboratory use only and is not meant for human consumption outside of controlled research settings.

    Warning: AOD-9604 is an investigational compound with limited evidence of efficacy in humans. Its use without medical supervision is not recommended due to the lack of long-term safety data and potential risks.